Steatotic Liver Disease Clinical Trials in Madrid
4 recruitingMadrid, Spain
Showing 1–4 of 4 trials
Recruiting
A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
Metabolic Dysfunction-Associated Steatotic Liver DiseasePlaque Psoriasis
Novartis Pharmaceuticals150 enrolled3 locationsNCT07683065
Recruiting
Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company4,500 enrolled563 locationsNCT07165028
Recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc.1,350 enrolled361 locationsNCT06318169
Recruiting
Phase 1Phase 2
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
Liver DiseasesCirrhosis, LiverDecompensated Liver Cirrhosis+5 more
Resolution Therapeutics Limited30 enrolled14 locationsNCT06823713